Several significant business and policy developments emerged across international markets this week, spanning multiple sectors and regions.

In European diplomatic circles, France has proposed changes to EU foreign policy structure that would create an enhanced role for foreign policy chief Kaja Kallas, according to internal documents. The proposal comes as the European Union continues to reassess its diplomatic approach amid ongoing global tensions.

The energy sector saw notable activity with CME Group announcing plans to expand 24-hour trading for WTI crude oil and gold futures. Separately, Venture Global reached an agreement with Greece's Atlantic-SEE to double their U.S. liquefied natural gas supply arrangement, reflecting continued shifts in global energy markets.

In the defense industry, German arms manufacturer Diehl entered discussions to produce Ukrainian missiles within Germany, marking a potential expansion of European defense manufacturing capabilities. This development aligns with broader European efforts to strengthen defense industrial capacity.

Healthcare and pharmaceutical sectors also recorded significant moves. The UK approved Novo Nordisk's weight-loss medication, potentially opening broader European market access for the treatment. Meanwhile, Amgen hired Duke University's research organization in an effort to prevent its drug Tavneos from market removal.

Corporate acquisition activity included Belden's pricing of a $1.85 billion term loan to finance its acquisition of RUCKUS Networks. Additionally, US Foods secured a $167 million contract with the U.S. Navy for comprehensive food and beverage supply services, demonstrating continued government contracting activity in essential services.